Gilead Sciences, Inc. (GILD)
151.00
-0.22
(-0.15%)
USD |
NASDAQ |
Sep 04, 16:00
150.90
-0.10
(-0.06%)
After-Hours: 20:00
Gilead Sciences Net Income (Annual) : 8.51B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.51B |
| December 31, 2024 | 480.00M |
| December 31, 2023 | 5.612B |
| December 31, 2022 | 4.566B |
| December 31, 2021 | 6.201B |
| December 31, 2020 | 89.00M |
| December 31, 2019 | 5.364B |
| December 31, 2018 | 5.46B |
| December 31, 2017 | 4.644B |
| December 31, 2016 | 13.49B |
| December 31, 2015 | 18.11B |
| December 31, 2014 | 12.06B |
| December 31, 2013 | 3.057B |
| December 31, 2012 | 2.574B |
| December 31, 2011 | 2.789B |
| December 31, 2010 | 2.890B |
| December 31, 2009 | 2.626B |
| Date | Value |
|---|---|
| December 31, 2008 | 2.003B |
| December 31, 2007 | 1.606B |
| December 31, 2006 | -1.196B |
| December 31, 2005 | 809.92M |
| December 31, 2004 | 449.37M |
| December 31, 2003 | -72.00M |
| December 31, 2002 | 72.10M |
| December 31, 2001 | 51.18M |
| December 31, 2000 | -43.11M |
| December 31, 1999 | -66.49M |
| December 31, 1998 | -56.08M |
| December 31, 1997 | -27.99M |
| December 31, 1996 | -21.73M |
| December 31, 1995 | -31.27M |
| March 31, 1994 | -25.71M |
| March 31, 1993 | -14.08M |
| March 31, 1992 | -4.517M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.953B |
| AbbVie, Inc. | 4.193B |
| Regeneron Pharmaceuticals, Inc. | 4.505B |
| Amgen, Inc. | 7.711B |
| Biogen, Inc. | 1.293B |